Brief: Waverley Pharma Inc Sees Net Revenue Of $200,000 For Quarter Ended Dec. 31, 2018
11/03/2019 12:39
March 11 (Reuters) - Waverley Pharma Inc WAVE.V :
* WAVERLEY PHARMA PROVIDES MARKET UPDATE AND FISCAL 2018
PRELIMINARY REVENUE
* WAVERLEY PHARMA INC - ESTIMATED NET REVENUE IS $200,000
FOR
QUARTER ENDED DECEMBER 31, 2018
Source text for Eikon: ID:nCNWMSNksa
Further company coverage: WAVE.V
(Reuters.Briefs@thomsonreuters.com)
Recent news on Waverley Pharma
See all newsBrief: Waverley Pharma Announces Chief Financial Officer Change
Brief: Waverley Pharma Acquires Us Based Pharmacy
Brief: Waverley Pharma Business Update
Brief: Waverley Pharma Provides Update On Its Parp-1 Inhibitor Program
Brief: Waverley Pharma - Co's Unit Awarded Exclusive Distribution Rights For Two Strengths Of Pemetrexed By NHS England